マイコプラズマガリセプチカムワクチンのグローバル市場インサイト・予測（～2027年）

• 英文タイトル：Global Mycoplasma Galliscepticum Vaccine Market Insights and Forecast to 2027

• レポートコード：QY2112C03890 • 出版社/出版日：QYResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥686,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,029,000 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,372,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査資料はマイコプラズマガリセプチカムワクチンの世界市場の現状について調査・分析し、2027年までの市場を予測しました。マイコプラズマガリセプチカムワクチンの世界市場概要、メーカー別の競争状況と市場シェア、種類別市場規模（生、不活化）、用途別市場規模（動物薬局、オンライン販売、その他）、主要地域別市場規模（北米・アメリカ、ヨーロッパ、アジア・日本・中国・インド、中南米、中東・アフリカ）、関連企業の情報、バリューチェーン・販売チャネル、市場動向などを収録しています。 ・マイコプラズマガリセプチカムワクチンの世界市場概要 ・メーカー別の競争状況、市場シェア ・マイコプラズマガリセプチカムワクチンの種類別市場規模：生、不活化 ・マイコプラズマガリセプチカムワクチンの用途別市場規模：動物薬局、オンライン販売、その他 ・北米のマイコプラズマガリセプチカムワクチン市場規模2016-2027：種類別、用途別、国別（アメリカ、カナダ） ・ヨーロッパのマイコプラズマガリセプチカムワクチン市場規模2016-2027：種類別、用途別、国別（ドイツ、フランス、イギリス） ・アジアのマイコプラズマガリセプチカムワクチン市場規模2016-2027：種類別、用途別、国別（日本、中国、インド、韓国） ・中南米のマイコプラズマガリセプチカムワクチン市場規模2016-2027：種類別、用途別、国別（メキシコ、ブラジル） ・中東・アフリカのマイコプラズマガリセプチカムワクチン市場規模2016-2027：種類別、用途別、国別（トルコ、サウジアラビア） ・企業情報：Merck、Ceva、Zoetis、Boehringer Ingelheim、Elanco、Shandong Huahong Biological Engineering Co., Ltd.、Jilin Zhengye Biological Products Co., Ltd.、Qingdao Yibang Biological Engineering Co., Ltd.、Shandong Lvdu Biological Technology Co., Ltd.、Ruipu Biopharmaceutical Co., Ltd. ・マイコプラズマガリセプチカムワクチンのバリューチェーン・販売チャネル分析 ・マイコプラズマガリセプチカムワクチンの世界市場動向

Mycoplasma Galliscepticum Vaccine is used to prevent chronic respiratory diseases in chickens caused by Mycoplasma gallisepticum.

Market Analysis and Insights: Global Mycoplasma Galliscepticum Vaccine Market
The global Mycoplasma Galliscepticum Vaccine market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.

Global Mycoplasma Galliscepticum Vaccine Scope and Segment
Mycoplasma Galliscepticum Vaccine market is segmented by Type, and by Distribution Channel. Players, stakeholders, and other participants in the global Mycoplasma Galliscepticum Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Distribution Channel for the period 2016-2027.

Segment by Type
Live
Inactivated

Segment by Distribution Channel
Veterinary Pharmacy
Online Sale
Others

By Company
Merck
Ceva
Zoetis
Boehringer Ingelheim
Elanco
Shandong Huahong Biological Engineering Co., Ltd.
Jilin Zhengye Biological Products Co., Ltd.
Qingdao Yibang Biological Engineering Co., Ltd.
Shandong Lvdu Biological Technology Co., Ltd.
Ruipu Biopharmaceutical Co., Ltd.

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Mycoplasma Galliscepticum Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Mycoplasma Galliscepticum Vaccine Market Size Growth Rate by Type
1.2.2 Live
1.2.3 Inactivated
1.3 Market by Distribution Channel
1.3.1 Global Mycoplasma Galliscepticum Vaccine Market Size Growth Rate by Distribution Channel
1.3.2 Veterinary Pharmacy
1.3.3 Online Sale
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Mycoplasma Galliscepticum Vaccine Sales Estimates and Forecasts 2016-2027
2.2 Global Mycoplasma Galliscepticum Vaccine Revenue Estimates and Forecasts 2016-2027
2.3 Global Mycoplasma Galliscepticum Vaccine Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Mycoplasma Galliscepticum Vaccine Regions by Sales
2.4.1 Global Top Mycoplasma Galliscepticum Vaccine Regions by Sales (2016-2021)
2.4.2 Global Top Mycoplasma Galliscepticum Vaccine Regions by Sales (2022-2027)
2.5 Global Top Mycoplasma Galliscepticum Vaccine Regions by Revenue
2.5.1 Global Top Mycoplasma Galliscepticum Vaccine Regions by Revenue (2016-2021)
2.5.2 Global Top Mycoplasma Galliscepticum Vaccine Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa

3 Competition by Manufacturers
3.1 Global Mycoplasma Galliscepticum Vaccine Sales by Manufacturers
3.1.1 Global Top Mycoplasma Galliscepticum Vaccine Manufacturers by Sales (2016-2021)
3.1.2 Global Top Mycoplasma Galliscepticum Vaccine Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Mycoplasma Galliscepticum Vaccine Sales in 2020
3.2 Global Mycoplasma Galliscepticum Vaccine Revenue by Manufacturers
3.2.1 Global Top Mycoplasma Galliscepticum Vaccine Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Mycoplasma Galliscepticum Vaccine Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Mycoplasma Galliscepticum Vaccine Revenue in 2020
3.3 Global Mycoplasma Galliscepticum Vaccine Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Mycoplasma Galliscepticum Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Mycoplasma Galliscepticum Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Mycoplasma Galliscepticum Vaccine Sales by Type
4.1.1 Global Mycoplasma Galliscepticum Vaccine Historical Sales by Type (2016-2021)
4.1.2 Global Mycoplasma Galliscepticum Vaccine Forecasted Sales by Type (2022-2027)
4.1.3 Global Mycoplasma Galliscepticum Vaccine Sales Market Share by Type (2016-2027)
4.2 Global Mycoplasma Galliscepticum Vaccine Revenue by Type
4.2.1 Global Mycoplasma Galliscepticum Vaccine Historical Revenue by Type (2016-2021)
4.2.2 Global Mycoplasma Galliscepticum Vaccine Forecasted Revenue by Type (2022-2027)
4.2.3 Global Mycoplasma Galliscepticum Vaccine Revenue Market Share by Type (2016-2027)
4.3 Global Mycoplasma Galliscepticum Vaccine Price by Type
4.3.1 Global Mycoplasma Galliscepticum Vaccine Price by Type (2016-2021)
4.3.2 Global Mycoplasma Galliscepticum Vaccine Price Forecast by Type (2022-2027)

5 Market Size by Application
5.1 Global Mycoplasma Galliscepticum Vaccine Sales by Distribution Channel
5.1.1 Global Mycoplasma Galliscepticum Vaccine Historical Sales by Distribution Channel (2016-2021)
5.1.2 Global Mycoplasma Galliscepticum Vaccine Forecasted Sales by Distribution Channel (2022-2027)
5.1.3 Global Mycoplasma Galliscepticum Vaccine Sales Market Share by Distribution Channel (2016-2027)
5.2 Global Mycoplasma Galliscepticum Vaccine Revenue by Distribution Channel
5.2.1 Global Mycoplasma Galliscepticum Vaccine Historical Revenue by Distribution Channel (2016-2021)
5.2.2 Global Mycoplasma Galliscepticum Vaccine Forecasted Revenue by Distribution Channel (2022-2027)
5.2.3 Global Mycoplasma Galliscepticum Vaccine Revenue Market Share by Distribution Channel (2016-2027)
5.3 Global Mycoplasma Galliscepticum Vaccine Price by Distribution Channel
5.3.1 Global Mycoplasma Galliscepticum Vaccine Price by Distribution Channel (2016-2021)
5.3.2 Global Mycoplasma Galliscepticum Vaccine Price Forecast by Distribution Channel (2022-2027)

6 North America
6.1 North America Mycoplasma Galliscepticum Vaccine Market Size by Type
6.1.1 North America Mycoplasma Galliscepticum Vaccine Sales by Type (2016-2027)
6.1.2 North America Mycoplasma Galliscepticum Vaccine Revenue by Type (2016-2027)
6.2 North America Mycoplasma Galliscepticum Vaccine Market Size by Distribution Channel
6.2.1 North America Mycoplasma Galliscepticum Vaccine Sales by Distribution Channel (2016-2027)
6.2.2 North America Mycoplasma Galliscepticum Vaccine Revenue by Distribution Channel (2016-2027)
6.3 North America Mycoplasma Galliscepticum Vaccine Market Size by Country
6.3.1 North America Mycoplasma Galliscepticum Vaccine Sales by Country (2016-2027)
6.3.2 North America Mycoplasma Galliscepticum Vaccine Revenue by Country (2016-2027)
6.3.3 United States
6.3.4 Canada

7 Europe
7.1 Europe Mycoplasma Galliscepticum Vaccine Market Size by Type
7.1.1 Europe Mycoplasma Galliscepticum Vaccine Sales by Type (2016-2027)
7.1.2 Europe Mycoplasma Galliscepticum Vaccine Revenue by Type (2016-2027)
7.2 Europe Mycoplasma Galliscepticum Vaccine Market Size by Distribution Channel
7.2.1 Europe Mycoplasma Galliscepticum Vaccine Sales by Distribution Channel (2016-2027)
7.2.2 Europe Mycoplasma Galliscepticum Vaccine Revenue by Distribution Channel (2016-2027)
7.3 Europe Mycoplasma Galliscepticum Vaccine Market Size by Country
7.3.1 Europe Mycoplasma Galliscepticum Vaccine Sales by Country (2016-2027)
7.3.2 Europe Mycoplasma Galliscepticum Vaccine Revenue by Country (2016-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia

8 Asia Pacific
8.1 Asia Pacific Mycoplasma Galliscepticum Vaccine Market Size by Type
8.1.1 Asia Pacific Mycoplasma Galliscepticum Vaccine Sales by Type (2016-2027)
8.1.2 Asia Pacific Mycoplasma Galliscepticum Vaccine Revenue by Type (2016-2027)
8.2 Asia Pacific Mycoplasma Galliscepticum Vaccine Market Size by Distribution Channel
8.2.1 Asia Pacific Mycoplasma Galliscepticum Vaccine Sales by Distribution Channel (2016-2027)
8.2.2 Asia Pacific Mycoplasma Galliscepticum Vaccine Revenue by Distribution Channel (2016-2027)
8.3 Asia Pacific Mycoplasma Galliscepticum Vaccine Market Size by Region
8.3.1 Asia Pacific Mycoplasma Galliscepticum Vaccine Sales by Region (2016-2027)
8.3.2 Asia Pacific Mycoplasma Galliscepticum Vaccine Revenue by Region (2016-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia

9 Latin America
9.1 Latin America Mycoplasma Galliscepticum Vaccine Market Size by Type
9.1.1 Latin America Mycoplasma Galliscepticum Vaccine Sales by Type (2016-2027)
9.1.2 Latin America Mycoplasma Galliscepticum Vaccine Revenue by Type (2016-2027)
9.2 Latin America Mycoplasma Galliscepticum Vaccine Market Size by Distribution Channel
9.2.1 Latin America Mycoplasma Galliscepticum Vaccine Sales by Distribution Channel (2016-2027)
9.2.2 Latin America Mycoplasma Galliscepticum Vaccine Revenue by Distribution Channel (2016-2027)
9.3 Latin America Mycoplasma Galliscepticum Vaccine Market Size by Country
9.3.1 Latin America Mycoplasma Galliscepticum Vaccine Sales by Country (2016-2027)
9.3.2 Latin America Mycoplasma Galliscepticum Vaccine Revenue by Country (2016-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia

10 Middle East and Africa
10.1 Middle East and Africa Mycoplasma Galliscepticum Vaccine Market Size by Type
10.1.1 Middle East and Africa Mycoplasma Galliscepticum Vaccine Sales by Type (2016-2027)
10.1.2 Middle East and Africa Mycoplasma Galliscepticum Vaccine Revenue by Type (2016-2027)
10.2 Middle East and Africa Mycoplasma Galliscepticum Vaccine Market Size by Distribution Channel
10.2.1 Middle East and Africa Mycoplasma Galliscepticum Vaccine Sales by Distribution Channel (2016-2027)
10.2.2 Middle East and Africa Mycoplasma Galliscepticum Vaccine Revenue by Distribution Channel (2016-2027)
10.3 Middle East and Africa Mycoplasma Galliscepticum Vaccine Market Size by Country
10.3.1 Middle East and Africa Mycoplasma Galliscepticum Vaccine Sales by Country (2016-2027)
10.3.2 Middle East and Africa Mycoplasma Galliscepticum Vaccine Revenue by Country (2016-2027)
10.3.3 Turkey
10.3.4 Saudi Arabia

11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Overview
11.1.3 Merck Mycoplasma Galliscepticum Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Merck Mycoplasma Galliscepticum Vaccine Product Description
11.1.5 Merck Recent Developments
11.2 Ceva
11.2.1 Ceva Corporation Information
11.2.2 Ceva Overview
11.2.3 Ceva Mycoplasma Galliscepticum Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Ceva Mycoplasma Galliscepticum Vaccine Product Description
11.2.5 Ceva Recent Developments
11.3 Zoetis
11.3.1 Zoetis Corporation Information
11.3.2 Zoetis Overview
11.3.3 Zoetis Mycoplasma Galliscepticum Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Zoetis Mycoplasma Galliscepticum Vaccine Product Description
11.3.5 Zoetis Recent Developments
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Corporation Information
11.4.2 Boehringer Ingelheim Overview
11.4.3 Boehringer Ingelheim Mycoplasma Galliscepticum Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Boehringer Ingelheim Mycoplasma Galliscepticum Vaccine Product Description
11.4.5 Boehringer Ingelheim Recent Developments
11.5 Elanco
11.5.1 Elanco Corporation Information
11.5.2 Elanco Overview
11.5.3 Elanco Mycoplasma Galliscepticum Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Elanco Mycoplasma Galliscepticum Vaccine Product Description
11.5.5 Elanco Recent Developments
11.6 Shandong Huahong Biological Engineering Co., Ltd.
11.6.1 Shandong Huahong Biological Engineering Co., Ltd. Corporation Information
11.6.2 Shandong Huahong Biological Engineering Co., Ltd. Overview
11.6.3 Shandong Huahong Biological Engineering Co., Ltd. Mycoplasma Galliscepticum Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Shandong Huahong Biological Engineering Co., Ltd. Mycoplasma Galliscepticum Vaccine Product Description
11.6.5 Shandong Huahong Biological Engineering Co., Ltd. Recent Developments
11.7 Jilin Zhengye Biological Products Co., Ltd.
11.7.1 Jilin Zhengye Biological Products Co., Ltd. Corporation Information
11.7.2 Jilin Zhengye Biological Products Co., Ltd. Overview
11.7.3 Jilin Zhengye Biological Products Co., Ltd. Mycoplasma Galliscepticum Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Jilin Zhengye Biological Products Co., Ltd. Mycoplasma Galliscepticum Vaccine Product Description
11.7.5 Jilin Zhengye Biological Products Co., Ltd. Recent Developments
11.8 Qingdao Yibang Biological Engineering Co., Ltd.
11.8.1 Qingdao Yibang Biological Engineering Co., Ltd. Corporation Information
11.8.2 Qingdao Yibang Biological Engineering Co., Ltd. Overview
11.8.3 Qingdao Yibang Biological Engineering Co., Ltd. Mycoplasma Galliscepticum Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 Qingdao Yibang Biological Engineering Co., Ltd. Mycoplasma Galliscepticum Vaccine Product Description
11.8.5 Qingdao Yibang Biological Engineering Co., Ltd. Recent Developments
11.9 Shandong Lvdu Biological Technology Co., Ltd.
11.9.1 Shandong Lvdu Biological Technology Co., Ltd. Corporation Information
11.9.2 Shandong Lvdu Biological Technology Co., Ltd. Overview
11.9.3 Shandong Lvdu Biological Technology Co., Ltd. Mycoplasma Galliscepticum Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Shandong Lvdu Biological Technology Co., Ltd. Mycoplasma Galliscepticum Vaccine Product Description
11.9.5 Shandong Lvdu Biological Technology Co., Ltd. Recent Developments
11.10 Ruipu Biopharmaceutical Co., Ltd.
11.10.1 Ruipu Biopharmaceutical Co., Ltd. Corporation Information
11.10.2 Ruipu Biopharmaceutical Co., Ltd. Overview
11.10.3 Ruipu Biopharmaceutical Co., Ltd. Mycoplasma Galliscepticum Vaccine Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Ruipu Biopharmaceutical Co., Ltd. Mycoplasma Galliscepticum Vaccine Product Description
11.10.5 Ruipu Biopharmaceutical Co., Ltd. Recent Developments

12 Value Chain and Sales Channels Analysis
12.1 Mycoplasma Galliscepticum Vaccine Value Chain Analysis
12.2 Mycoplasma Galliscepticum Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Mycoplasma Galliscepticum Vaccine Production Mode & Process
12.4 Mycoplasma Galliscepticum Vaccine Sales and Marketing
12.4.1 Mycoplasma Galliscepticum Vaccine Sales Channels
12.4.2 Mycoplasma Galliscepticum Vaccine Distributors
12.5 Mycoplasma Galliscepticum Vaccine Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Mycoplasma Galliscepticum Vaccine Industry Trends
13.2 Mycoplasma Galliscepticum Vaccine Market Drivers
13.3 Mycoplasma Galliscepticum Vaccine Market Challenges
13.4 Mycoplasma Galliscepticum Vaccine Market Restraints

14 Key Findings in The Global Mycoplasma Galliscepticum Vaccine Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Mycoplasma Galliscepticum Vaccine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Live
Table 3. Major Manufacturers of Inactivated
Table 4. Global Mycoplasma Galliscepticum Vaccine Market Size Growth Rate by Distribution Channel, 2016 VS 2021 VS 2027 (US$ Million)
Table 5. Global Mycoplasma Galliscepticum Vaccine Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 6. Global Mycoplasma Galliscepticum Vaccine Sales by Region (2016-2021) & (K Units)
Table 7. Global Mycoplasma Galliscepticum Vaccine Sales Market Share by Region (2016-2021)
Table 8. Global Mycoplasma Galliscepticum Vaccine Sales by Region (2022-2027) & (K Units)
Table 9. Global Mycoplasma Galliscepticum Vaccine Sales Market Share by Region (2022-2027)
Table 10. Global Mycoplasma Galliscepticum Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 11. Global Mycoplasma Galliscepticum Vaccine Revenue Market Share by Region (2016-2021)
Table 12. Global Mycoplasma Galliscepticum Vaccine Revenue by Region (2022-2027) & (US$ Million)
Table 13. Global Mycoplasma Galliscepticum Vaccine Revenue Market Share by Region (2022-2027)
Table 14. Global Mycoplasma Galliscepticum Vaccine Sales by Manufacturers (2016-2021) & (K Units)
Table 15. Global Mycoplasma Galliscepticum Vaccine Sales Share by Manufacturers (2016-2021)
Table 16. Global Mycoplasma Galliscepticum Vaccine Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 17. Global Mycoplasma Galliscepticum Vaccine Revenue Share by Manufacturers (2016-2021)
Table 18. Mycoplasma Galliscepticum Vaccine Price by Manufacturers 2016-2021 (US$/Unit)
Table 19. Global Mycoplasma Galliscepticum Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Mycoplasma Galliscepticum Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mycoplasma Galliscepticum Vaccine as of 2020)
Table 21. Mycoplasma Galliscepticum Vaccine Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Mycoplasma Galliscepticum Vaccine Product Offered
Table 23. Date of Manufacturers Enter into Mycoplasma Galliscepticum Vaccine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Mycoplasma Galliscepticum Vaccine Sales by Type (2016-2021) & (K Units)
Table 26. Global Mycoplasma Galliscepticum Vaccine Sales by Type (2022-2027) & (K Units)
Table 27. Global Mycoplasma Galliscepticum Vaccine Sales Share by Type (2016-2021)
Table 28. Global Mycoplasma Galliscepticum Vaccine Sales Share by Type (2022-2027)
Table 29. Global Mycoplasma Galliscepticum Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 30. Global Mycoplasma Galliscepticum Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 31. Global Mycoplasma Galliscepticum Vaccine Revenue Share by Type (2016-2021)
Table 32. Global Mycoplasma Galliscepticum Vaccine Revenue Share by Type (2022-2027)
Table 33. Mycoplasma Galliscepticum Vaccine Price by Type (2016-2021) & (US$/Unit)
Table 34. Global Mycoplasma Galliscepticum Vaccine Price Forecast by Type (2022-2027) & (US$/Unit)
Table 35. Global Mycoplasma Galliscepticum Vaccine Sales by Distribution Channel (2016-2021) & (K Units)
Table 36. Global Mycoplasma Galliscepticum Vaccine Sales by Distribution Channel (2022-2027) & (K Units)
Table 37. Global Mycoplasma Galliscepticum Vaccine Sales Share by Distribution Channel (2016-2021)
Table 38. Global Mycoplasma Galliscepticum Vaccine Sales Share by Distribution Channel (2022-2027)
Table 39. Global Mycoplasma Galliscepticum Vaccine Revenue by Distribution Channel (2016-2021) & (US$ Million)
Table 40. Global Mycoplasma Galliscepticum Vaccine Revenue by Distribution Channel (2022-2027) & (US$ Million)
Table 41. Global Mycoplasma Galliscepticum Vaccine Revenue Share by Distribution Channel (2016-2021)
Table 42. Global Mycoplasma Galliscepticum Vaccine Revenue Share by Distribution Channel (2022-2027)
Table 43. Mycoplasma Galliscepticum Vaccine Price by Distribution Channel (2016-2021) & (US$/Unit)
Table 44. Global Mycoplasma Galliscepticum Vaccine Price Forecast by Distribution Channel (2022-2027) & (US$/Unit)
Table 45. North America Mycoplasma Galliscepticum Vaccine Sales by Type (2016-2021) & (K Units)
Table 46. North America Mycoplasma Galliscepticum Vaccine Sales by Type (2022-2027) & (K Units)
Table 47. North America Mycoplasma Galliscepticum Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 48. North America Mycoplasma Galliscepticum Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 49. North America Mycoplasma Galliscepticum Vaccine Sales by Distribution Channel (2016-2021) & (K Units)
Table 50. North America Mycoplasma Galliscepticum Vaccine Sales by Distribution Channel (2022-2027) & (K Units)
Table 51. North America Mycoplasma Galliscepticum Vaccine Revenue by Distribution Channel (2016-2021) & (US$ Million)
Table 52. North America Mycoplasma Galliscepticum Vaccine Revenue by Distribution Channel (2022-2027) & (US$ Million)
Table 53. North America Mycoplasma Galliscepticum Vaccine Sales by Country (2016-2021) & (K Units)
Table 54. North America Mycoplasma Galliscepticum Vaccine Sales by Country (2022-2027) & (K Units)
Table 55. North America Mycoplasma Galliscepticum Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 56. North America Mycoplasma Galliscepticum Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 57. Europe Mycoplasma Galliscepticum Vaccine Sales by Type (2016-2021) & (K Units)
Table 58. Europe Mycoplasma Galliscepticum Vaccine Sales by Type (2022-2027) & (K Units)
Table 59. Europe Mycoplasma Galliscepticum Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 60. Europe Mycoplasma Galliscepticum Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 61. Europe Mycoplasma Galliscepticum Vaccine Sales by Distribution Channel (2016-2021) & (K Units)
Table 62. Europe Mycoplasma Galliscepticum Vaccine Sales by Distribution Channel (2022-2027) & (K Units)
Table 63. Europe Mycoplasma Galliscepticum Vaccine Revenue by Distribution Channel (2016-2021) & (US$ Million)
Table 64. Europe Mycoplasma Galliscepticum Vaccine Revenue by Distribution Channel (2022-2027) & (US$ Million)
Table 65. Europe Mycoplasma Galliscepticum Vaccine Sales by Country (2016-2021) & (K Units)
Table 66. Europe Mycoplasma Galliscepticum Vaccine Sales by Country (2022-2027) & (K Units)
Table 67. Europe Mycoplasma Galliscepticum Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 68. Europe Mycoplasma Galliscepticum Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 69. Asia Pacific Mycoplasma Galliscepticum Vaccine Sales by Type (2016-2021) & (K Units)
Table 70. Asia Pacific Mycoplasma Galliscepticum Vaccine Sales by Type (2022-2027) & (K Units)
Table 71. Asia Pacific Mycoplasma Galliscepticum Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 72. Asia Pacific Mycoplasma Galliscepticum Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 73. Asia Pacific Mycoplasma Galliscepticum Vaccine Sales by Distribution Channel (2016-2021) & (K Units)
Table 74. Asia Pacific Mycoplasma Galliscepticum Vaccine Sales by Distribution Channel (2022-2027) & (K Units)
Table 75. Asia Pacific Mycoplasma Galliscepticum Vaccine Revenue by Distribution Channel (2016-2021) & (US$ Million)
Table 76. Asia Pacific Mycoplasma Galliscepticum Vaccine Revenue by Distribution Channel (2022-2027) & (US$ Million)
Table 77. Asia Pacific Mycoplasma Galliscepticum Vaccine Sales by Region (2016-2021) & (K Units)
Table 78. Asia Pacific Mycoplasma Galliscepticum Vaccine Sales by Region (2022-2027) & (K Units)
Table 79. Asia Pacific Mycoplasma Galliscepticum Vaccine Revenue by Region (2016-2021) & (US$ Million)
Table 80. Asia Pacific Mycoplasma Galliscepticum Vaccine Revenue by Region (2022-2027) & (US$ Million)
Table 81. Latin America Mycoplasma Galliscepticum Vaccine Sales by Type (2016-2021) & (K Units)
Table 82. Latin America Mycoplasma Galliscepticum Vaccine Sales by Type (2022-2027) & (K Units)
Table 83. Latin America Mycoplasma Galliscepticum Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 84. Latin America Mycoplasma Galliscepticum Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 85. Latin America Mycoplasma Galliscepticum Vaccine Sales by Distribution Channel (2016-2021) & (K Units)
Table 86. Latin America Mycoplasma Galliscepticum Vaccine Sales by Distribution Channel (2022-2027) & (K Units)
Table 87. Latin America Mycoplasma Galliscepticum Vaccine Revenue by Distribution Channel (2016-2021) & (US$ Million)
Table 88. Latin America Mycoplasma Galliscepticum Vaccine Revenue by Distribution Channel (2022-2027) & (US$ Million)
Table 89. Latin America Mycoplasma Galliscepticum Vaccine Sales by Country (2016-2021) & (K Units)
Table 90. Latin America Mycoplasma Galliscepticum Vaccine Sales by Country (2022-2027) & (K Units)
Table 91. Latin America Mycoplasma Galliscepticum Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 92. Latin America Mycoplasma Galliscepticum Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 93. Middle East and Africa Mycoplasma Galliscepticum Vaccine Sales by Type (2016-2021) & (K Units)
Table 94. Middle East and Africa Mycoplasma Galliscepticum Vaccine Sales by Type (2022-2027) & (K Units)
Table 95. Middle East and Africa Mycoplasma Galliscepticum Vaccine Revenue by Type (2016-2021) & (US$ Million)
Table 96. Middle East and Africa Mycoplasma Galliscepticum Vaccine Revenue by Type (2022-2027) & (US$ Million)
Table 97. Middle East and Africa Mycoplasma Galliscepticum Vaccine Sales by Distribution Channel (2016-2021) & (K Units)
Table 98. Middle East and Africa Mycoplasma Galliscepticum Vaccine Sales by Distribution Channel (2022-2027) & (K Units)
Table 99. Middle East and Africa Mycoplasma Galliscepticum Vaccine Revenue by Distribution Channel (2016-2021) & (US$ Million)
Table 100. Middle East and Africa Mycoplasma Galliscepticum Vaccine Revenue by Distribution Channel (2022-2027) & (US$ Million)
Table 101. Middle East and Africa Mycoplasma Galliscepticum Vaccine Sales by Country (2016-2021) & (K Units)
Table 102. Middle East and Africa Mycoplasma Galliscepticum Vaccine Sales by Country (2022-2027) & (K Units)
Table 103. Middle East and Africa Mycoplasma Galliscepticum Vaccine Revenue by Country (2016-2021) & (US$ Million)
Table 104. Middle East and Africa Mycoplasma Galliscepticum Vaccine Revenue by Country (2022-2027) & (US$ Million)
Table 105. Merck Corporation Information
Table 106. Merck Description and Major Businesses
Table 107. Merck Mycoplasma Galliscepticum Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 108. Merck Mycoplasma Galliscepticum Vaccine Product
Table 109. Merck Recent Developments
Table 110. Ceva Corporation Information
Table 111. Ceva Description and Major Businesses
Table 112. Ceva Mycoplasma Galliscepticum Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 113. Ceva Mycoplasma Galliscepticum Vaccine Product
Table 114. Ceva Recent Developments
Table 115. Zoetis Corporation Information
Table 116. Zoetis Description and Major Businesses
Table 117. Zoetis Mycoplasma Galliscepticum Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 118. Zoetis Mycoplasma Galliscepticum Vaccine Product
Table 119. Zoetis Recent Developments
Table 120. Boehringer Ingelheim Corporation Information
Table 121. Boehringer Ingelheim Description and Major Businesses
Table 122. Boehringer Ingelheim Mycoplasma Galliscepticum Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 123. Boehringer Ingelheim Mycoplasma Galliscepticum Vaccine Product
Table 124. Boehringer Ingelheim Recent Developments
Table 125. Elanco Corporation Information
Table 126. Elanco Description and Major Businesses
Table 127. Elanco Mycoplasma Galliscepticum Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 128. Elanco Mycoplasma Galliscepticum Vaccine Product
Table 129. Elanco Recent Developments
Table 130. Shandong Huahong Biological Engineering Co., Ltd. Corporation Information
Table 131. Shandong Huahong Biological Engineering Co., Ltd. Description and Major Businesses
Table 132. Shandong Huahong Biological Engineering Co., Ltd. Mycoplasma Galliscepticum Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 133. Shandong Huahong Biological Engineering Co., Ltd. Mycoplasma Galliscepticum Vaccine Product
Table 134. Shandong Huahong Biological Engineering Co., Ltd. Recent Developments
Table 135. Jilin Zhengye Biological Products Co., Ltd. Corporation Information
Table 136. Jilin Zhengye Biological Products Co., Ltd. Description and Major Businesses
Table 137. Jilin Zhengye Biological Products Co., Ltd. Mycoplasma Galliscepticum Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 138. Jilin Zhengye Biological Products Co., Ltd. Mycoplasma Galliscepticum Vaccine Product
Table 139. Jilin Zhengye Biological Products Co., Ltd. Recent Developments
Table 140. Qingdao Yibang Biological Engineering Co., Ltd. Corporation Information
Table 141. Qingdao Yibang Biological Engineering Co., Ltd. Description and Major Businesses
Table 142. Qingdao Yibang Biological Engineering Co., Ltd. Mycoplasma Galliscepticum Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 143. Qingdao Yibang Biological Engineering Co., Ltd. Mycoplasma Galliscepticum Vaccine Product
Table 144. Qingdao Yibang Biological Engineering Co., Ltd. Recent Developments
Table 145. Shandong Lvdu Biological Technology Co., Ltd. Corporation Information
Table 146. Shandong Lvdu Biological Technology Co., Ltd. Description and Major Businesses
Table 147. Shandong Lvdu Biological Technology Co., Ltd. Mycoplasma Galliscepticum Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 148. Shandong Lvdu Biological Technology Co., Ltd. Mycoplasma Galliscepticum Vaccine Product
Table 149. Shandong Lvdu Biological Technology Co., Ltd. Recent Developments
Table 150. Ruipu Biopharmaceutical Co., Ltd. Corporation Information
Table 151. Ruipu Biopharmaceutical Co., Ltd. Description and Major Businesses
Table 152. Ruipu Biopharmaceutical Co., Ltd. Mycoplasma Galliscepticum Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 153. Ruipu Biopharmaceutical Co., Ltd. Mycoplasma Galliscepticum Vaccine Product
Table 154. Ruipu Biopharmaceutical Co., Ltd. Recent Developments
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Mycoplasma Galliscepticum Vaccine Distributors List
Table 158. Mycoplasma Galliscepticum Vaccine Customers List
Table 159. Mycoplasma Galliscepticum Vaccine Market Trends
Table 160. Mycoplasma Galliscepticum Vaccine Market Drivers
Table 161. Mycoplasma Galliscepticum Vaccine Market Challenges
Table 162. Mycoplasma Galliscepticum Vaccine Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Mycoplasma Galliscepticum Vaccine Product Picture
Figure 2. Global Mycoplasma Galliscepticum Vaccine Market Share by Type in 2020 & 2027
Figure 3. Live Product Picture
Figure 4. Inactivated Product Picture
Figure 5. Global Mycoplasma Galliscepticum Vaccine Market Share by Distribution Channel in 2020 & 2027
Figure 6. Veterinary Pharmacy
Figure 7. Online Sale
Figure 8. Others
Figure 9. Mycoplasma Galliscepticum Vaccine Report Years Considered
Figure 10. Global Mycoplasma Galliscepticum Vaccine Sales 2016-2027 (K Units)
Figure 11. Global Mycoplasma Galliscepticum Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Mycoplasma Galliscepticum Vaccine Revenue 2016-2027 (US$ Million)
Figure 13. Global Mycoplasma Galliscepticum Vaccine Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 14. Global Mycoplasma Galliscepticum Vaccine Sales Market Share by Region (2016-2021)
Figure 15. Global Mycoplasma Galliscepticum Vaccine Sales Market Share by Region (2022-2027)
Figure 16. North America Mycoplasma Galliscepticum Vaccine Sales YoY (2016-2027) & (K Units)
Figure 17. North America Mycoplasma Galliscepticum Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 18. Europe Mycoplasma Galliscepticum Vaccine Sales YoY (2016-2027) & (K Units)
Figure 19. Europe Mycoplasma Galliscepticum Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 20. Asia-Pacific Mycoplasma Galliscepticum Vaccine Sales YoY (2016-2027) & (K Units)
Figure 21. Asia-Pacific Mycoplasma Galliscepticum Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Latin America Mycoplasma Galliscepticum Vaccine Sales YoY (2016-2027) & (K Units)
Figure 23. Latin America Mycoplasma Galliscepticum Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Middle East & Africa Mycoplasma Galliscepticum Vaccine Sales YoY (2016-2027) & (K Units)
Figure 25. Middle East & Africa Mycoplasma Galliscepticum Vaccine Revenue YoY (2016-2027) & (US$ Million)
Figure 26. The Top 10 and Top 5 Players Market Share by Mycoplasma Galliscepticum Vaccine Sales in 2020
Figure 27. The Top 10 and Top 5 Players Market Share by Mycoplasma Galliscepticum Vaccine Revenue in 2020
Figure 28. Mycoplasma Galliscepticum Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 29. Global Mycoplasma Galliscepticum Vaccine Sales Market Share by Type (2016-2027)
Figure 30. Global Mycoplasma Galliscepticum Vaccine Revenue Market Share by Type (2016-2027)
Figure 31. Global Mycoplasma Galliscepticum Vaccine Sales Market Share by Distribution Channel (2016-2027)
Figure 32. Global Mycoplasma Galliscepticum Vaccine Revenue Market Share by Distribution Channel (2016-2027)
Figure 33. North America Mycoplasma Galliscepticum Vaccine Sales Market Share by Type (2016-2027)
Figure 34. North America Mycoplasma Galliscepticum Vaccine Revenue Market Share by Type (2016-2027)
Figure 35. North America Mycoplasma Galliscepticum Vaccine Sales Market Share by Distribution Channel (2016-2027)
Figure 36. North America Mycoplasma Galliscepticum Vaccine Revenue Market Share by Distribution Channel (2016-2027)
Figure 37. North America Mycoplasma Galliscepticum Vaccine Sales Share by Country (2016-2027)
Figure 38. North America Mycoplasma Galliscepticum Vaccine Revenue Share by Country (2016-2027)
Figure 39. United States Mycoplasma Galliscepticum Vaccine Revenue (2016-2027) & (US$ Million)
Figure 40. Canada Mycoplasma Galliscepticum Vaccine Revenue (2016-2027) & (US$ Million)
Figure 41. Europe Mycoplasma Galliscepticum Vaccine Sales Market Share by Type (2016-2027)
Figure 42. Europe Mycoplasma Galliscepticum Vaccine Revenue Market Share by Type (2016-2027)
Figure 43. Europe Mycoplasma Galliscepticum Vaccine Sales Market Share by Distribution Channel (2016-2027)
Figure 44. Europe Mycoplasma Galliscepticum Vaccine Revenue Market Share by Distribution Channel (2016-2027)
Figure 45. Europe Mycoplasma Galliscepticum Vaccine Sales Share by Country (2016-2027)
Figure 46. Europe Mycoplasma Galliscepticum Vaccine Revenue Share by Country (2016-2027)
Figure 47. Germany Mycoplasma Galliscepticum Vaccine Revenue (2016-2027) & (US$ Million)
Figure 48. France Mycoplasma Galliscepticum Vaccine Revenue (2016-2027) & (US$ Million)
Figure 49. U.K. Mycoplasma Galliscepticum Vaccine Revenue (2016-2027) & (US$ Million)
Figure 50. Italy Mycoplasma Galliscepticum Vaccine Revenue (2016-2027) & (US$ Million)
Figure 51. Russia Mycoplasma Galliscepticum Vaccine Revenue (2016-2027) & (US$ Million)
Figure 52. Asia Pacific Mycoplasma Galliscepticum Vaccine Sales Market Share by Type (2016-2027)
Figure 53. Asia Pacific Mycoplasma Galliscepticum Vaccine Revenue Market Share by Type (2016-2027)
Figure 54. Asia Pacific Mycoplasma Galliscepticum Vaccine Sales Market Share by Distribution Channel (2016-2027)
Figure 55. Asia Pacific Mycoplasma Galliscepticum Vaccine Revenue Market Share by Distribution Channel (2016-2027)
Figure 56. Asia Pacific Mycoplasma Galliscepticum Vaccine Sales Share by Region (2016-2027)
Figure 57. Asia Pacific Mycoplasma Galliscepticum Vaccine Revenue Share by Region (2016-2027)
Figure 58. China Mycoplasma Galliscepticum Vaccine Revenue (2016-2027) & (US$ Million)
Figure 59. Japan Mycoplasma Galliscepticum Vaccine Revenue (2016-2027) & (US$ Million)
Figure 60. South Korea Mycoplasma Galliscepticum Vaccine Revenue (2016-2027) & (US$ Million)
Figure 61. India Mycoplasma Galliscepticum Vaccine Revenue (2016-2027) & (US$ Million)
Figure 62. Australia Mycoplasma Galliscepticum Vaccine Revenue (2016-2027) & (US$ Million)
Figure 63. China Taiwan Mycoplasma Galliscepticum Vaccine Revenue (2016-2027) & (US$ Million)
Figure 64. Indonesia Mycoplasma Galliscepticum Vaccine Revenue (2016-2027) & (US$ Million)
Figure 65. Thailand Mycoplasma Galliscepticum Vaccine Revenue (2016-2027) & (US$ Million)
Figure 66. Malaysia Mycoplasma Galliscepticum Vaccine Revenue (2016-2027) & (US$ Million)
Figure 67. Latin America Mycoplasma Galliscepticum Vaccine Sales Market Share by Type (2016-2027)
Figure 68. Latin America Mycoplasma Galliscepticum Vaccine Revenue Market Share by Type (2016-2027)
Figure 69. Latin America Mycoplasma Galliscepticum Vaccine Sales Market Share by Distribution Channel (2016-2027)
Figure 70. Latin America Mycoplasma Galliscepticum Vaccine Revenue Market Share by Distribution Channel (2016-2027)
Figure 71. Latin America Mycoplasma Galliscepticum Vaccine Sales Share by Country (2016-2027)
Figure 72. Latin America Mycoplasma Galliscepticum Vaccine Revenue Share by Country (2016-2027)
Figure 73. Mexico Mycoplasma Galliscepticum Vaccine Revenue (2016-2027) & (US$ Million)
Figure 74. Brazil Mycoplasma Galliscepticum Vaccine Revenue (2016-2027) & (US$ Million)
Figure 75. Argentina Mycoplasma Galliscepticum Vaccine Revenue (2016-2027) & (US$ Million)
Figure 76. Colombia Mycoplasma Galliscepticum Vaccine Revenue (2016-2027) & (US$ Million)
Figure 77. Middle East and Africa Mycoplasma Galliscepticum Vaccine Sales Market Share by Type (2016-2027)
Figure 78. Middle East and Africa Mycoplasma Galliscepticum Vaccine Revenue Market Share by Type (2016-2027)
Figure 79. Middle East and Africa Mycoplasma Galliscepticum Vaccine Sales Market Share by Distribution Channel (2016-2027)
Figure 80. Middle East and Africa Mycoplasma Galliscepticum Vaccine Revenue Market Share by Distribution Channel (2016-2027)
Figure 81. Middle East and Africa Mycoplasma Galliscepticum Vaccine Sales Share by Country (2016-2027)
Figure 82. Middle East and Africa Mycoplasma Galliscepticum Vaccine Revenue Share by Country (2016-2027)
Figure 83. Turkey Mycoplasma Galliscepticum Vaccine Revenue (2016-2027) & (US$ Million)
Figure 84. Saudi Arabia Mycoplasma Galliscepticum Vaccine Revenue (2016-2027) & (US$ Million)
Figure 85. UAE Mycoplasma Galliscepticum Vaccine Revenue (2016-2027) & (US$ Million)
Figure 86. Mycoplasma Galliscepticum Vaccine Value Chain
Figure 87. Mycoplasma Galliscepticum Vaccine Production Process
Figure 88. Channels of Distribution
Figure 89. Distributors Profiles
Figure 90. Bottom-up and Top-down Approaches for This Report
Figure 91. Data Triangulation
Figure 92. Key Executives Interviewed

---